La vendita allo scoperto per Magic Empire Glb dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Magic Empire Glb. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Magic Empire Glb (NASDAQ:MEGL) Azioni, Report sulle vendite allo scoperto

Magic Empire Global

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Magic Empire Global Limited - Ordinary Shares

Magic Empire Global Ltd

PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) has outperformed the market over the past 5 years by 10.01% on an annualized basis producing an average annual return of 23.27%. Currently, PDD Holdings has a market capitalization of $144.22 billion. 
Buying $1000 In PDD: If an investor had bought $1000 of PDD stock 5 years ago, it would be worth $2,789.23 today based on a price of $103.85 for PDD at the time of writing.
<h3>PDD Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737503109_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Citigourp Global Markets 2% Protected Notes Linked To The Djia

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

As the oldest members of <a href="https://www.benzinga.com/personal-finance/24/12/42325436/despite-having-the-highest-income-gen-x-also-carries-the-most-debt-explaining-their-rock-bottom-consumer-sentiment">Generation X</a> (those born between 1965 and 1980) approach retirement, financial experts warn that many in this group may not be as prepared as they think. Generation X faces unique challenges as they prepare for retired life, from shortfalls in savings to unexpected costs that may arise.&nbsp;
Here's what experts say Gen Xers need to know to avoid these key pitfalls and ensure a more <a href="https://www.benzinga.com/personal-finance/24/11/41918104/are-you-on-track-to-retire-rich-heres-the-nest-egg-you-need-to-be-considered-a-wealthy-retiree">secure retirement</a>.&nbsp;
<h2 class="wp-block-heading">Look At Your Savings Goals</h2>
Many Gen Xers are significantly behind in their retirement savings. A recent study by Northwestern Mutual found that only 7% of Gen X respondents have saved more than 10 times their annual income–the amount most experts recommend for a comfortable retirement.&nbsp;
Don't Miss:
<ul>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>The average 401(k) balance soars to a record-breaking high – <a href="https://www.benzinga.com/money/average-401k-balances-soars-to-record-high">but what&#8217;s driving it?</a></li>
</ul>
Perhaps even more concerning, over half of Gen X respondents say they have only saved three times their annual income or less. Fidelity recommends having at least three times your annual salary by age 40, six times your salary by age 50 and eight times your salary by age 60 to stay on track for a comfortable retirement.&nbsp;
This shortfall in savings is compounded by the fact that many Gen Xers do not have a <a href="https://www.benzinga.com/personal-finance/financial-advisors/24/11/41702991/americans-worried-theyll-mess-up-retirement-income-planning-almost-half-fear-">retirement income plan</a>. According to Allianz, only 30% of Gen Xers have mapped out how they will fund their post-work years, the lowest rate among all generations surveyed.
<h2 class="wp-block-heading">Taxes and Healthcare Expenses</h2>
A common misconception among Americans is that taxes decrease in retirement. However, financial experts caution that many Gen Xers could face higher-than-expected tax burdens. The reason? Most have their retirement savings in tax-deferred accounts, like <a href="https://www.benzinga.com/personal-finance/24/11/42154984/new-findings-show-iras-and-401ks-contribute-less-than-20-of-retirees-income">401(k)s and IRAs</a>, which require taxes to be paid upon withdrawal.&nbsp;
"The big problem is that a lot of them are going to be faced with a lot of taxes in retirement," Jonathan Dane, founder and chief investment officer for Defiant Capital Group in Pittsburgh, told U.S. News. He says one way to mitigate this is to stop putting money in tax-deferred accounts and transition to Roth accounts, which allow for tax-free withdrawals.
See Also: The Biggest Disruption to IP since Disney — <a href="https://www.benzinga.com/money/elf-labs-1">Get in now as they monetize a $2 Trillion market by building content around the most profitable Character IP in history and combining it with the Patented Technology IP of the future.</a>
Another concern is healthcare costs. While Medicare provides comprehensive coverage starting at age 65, it doesn't cover everything. Long-term care expenses, like assisted living, typically aren't included. Experts suggest considering long-term care insurance or using a health savings account (HSA) to prepare for these costs.&nbsp;
<h2 class="wp-block-heading">Budgeting and Withdrawal Strategies</h2>
Financial planners warn that many Gen Xers don't clearly understand their spending habits. "They've been getting a paycheck for the last 40 years and they just don't know what they spend," Zach Ungerott of Hightower Wealth Advisors told U.S. News.
Knowing when and how much to withdraw from savings can make a significant difference. Starting withdrawals at age 59 ½ allows penalty-free access to funds in tax-advantaged accounts, but withdrawing too much too quickly risks prematurely depleting savings.
Trending: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a>
<h2 class="wp-block-heading">Updating Estate Plans and Investments</h2>
Many Gen Xers have outdated estate plans that don't reflect their current wishes. Reviewing and updating wills, beneficiary designations and other documents is essential to ensure assets are distributed as intended.
Investment strategies may also need adjustment. While Gen X has benefited from stock market gains, experts suggest diversifying into more stable assets like bonds or annuities to protect against market downturns.
With retirement on the horizon, Generation X has limited time to close savings gaps, reassess strategies and prepare for potential obstacles. Working with a <a href="https://www.benzinga.com/money/best-online-financial-advisors">financial professional</a> can help this generation create a plan tailored to their needs, ensuring they are better positioned for a secure retirement.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/planning-your-retirement-new-changes-to-social-security-in-2025-could-affect-you">Planning Your Retirement? New Changes To Social Security In 2025 Could Affect You</a></li>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
</ul>

Personal Finance

'It Won't Be Enough': Financial Experts Warn Gen X About Key Retirement Pitfalls

Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) has outperformed the market over the past 5 years by 20.28% on an annualized basis producing an average annual return of 33.54%. Currently, Fortinet has a market capitalization of $74.35 billion. 
Buying $100 In FTNT: If an investor had bought $100 of FTNT stock 5 years ago, it would be worth $411.90 today based on a price of $97.00 for FTNT at the time of writing.
<h3>Fortinet's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737502210_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FTNT

$100 Invested In Fortinet 5 Years Ago Would Be Worth This Much Today

According to the latest data from the Centers for Disease Control and Prevention, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus. The virus was confirmed on Friday at a commercial poultry production facility in Georgia, the nation's top state <a href="https://www.benzinga.com/general/biotech/25/01/43046294/bird-flu-raising-red-flags-among-health-officials-cdc-urges-faster-testing">for chicken production. </a>
What To Know: The CDC said that the current public health risk is low and the agency is watching the situation carefully and monitoring people with animal exposures. Bird flu is "widespread in wild birds worldwide and is causing outbreaks in poultry and U.S. dairy cows with several recent human cases in U.S. dairy and poultry workers," the CDC stated in its <a href="https://www.cdc.gov/bird-flu/situation-summary/index.html">most recent</a> update.&nbsp;
On Friday, the Georgia Department of Agriculture announced it <a href="https://agr.georgia.gov/avian-influenza">detected</a> a case of Highly Pathogenic Avian Influenza at a commercial poultry producer in the state. The case marks the first in Georgia, the nation's top state for chicken production, since the 2022 countrywide outbreak. 
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">Trump Reverses Biden&#8217;s AI Policies On Day 1: What It Means For Tech Giants Nvidia, AMD, Alphabet&nbsp;</a>
"This is a serious threat to Georgia's #1 industry and the livelihoods of thousands of Georgians who make their living in our state's poultry industry," Georgia Agriculture Commissioner Tyler Harper said in a news release.&nbsp;
According to an AP News<a href="https://apnews.com/article/bird-flu-georgia-chicken-commercial-flock-a5bcad4662d4cf60212f6acb4a55d2ad"> report,</a> the bird flu virus has been detected in 84 commercial and backyard flocks in the past month with 10.7 million birds affected. The virus has also been confirmed in dozens of dairy farms.
What Else: On Friday, Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) announced <a href="https://www.benzinga.com/general/biotech/25/01/43105845/why-is-moderna-stock-trading-higher-on-tuesday-2">it received</a> an additional $590 million award from the U.S. Department of Health and Human Services (HHS) to accelerate the development of its mRNA-based influenza vaccines, including bird flu.
In 2023, Moderna commenced a Phase 1/2 study to generate safety and immunogenicity data for an investigational pandemic influenza vaccine (mRNA-1018) candidate against the H5 and H7 avian influenza viruses. Based on the preliminary data from the Phase 1/2 study, Moderna is preparing to advance mRNA-1018 into Phase 3. 
Other pharmaceutical companies, including Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>), have bird flu vaccine candidates currently in clinical trials. 
CureVac BV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) started a phase I/II study on its bird flu vaccine candidate developed in collaboration with GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>). 
Egg producer Cal-Maine Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NYSE">CALM</a>) reported<a href="https://www.benzinga.com/news/earnings/25/01/42862269/cal-maine-foods-stock-climbs-after-strong-q2-results-eps-beat-revenues-beat"> its most recent </a>quarterly revenue of $954.7 million, well above the  $751.49 million consensus estimate, due in part to restricted supply resulting from highly pathogenic avian influenza (HPAI) outbreaks. Cal-Maine Foods stock gained more than 75% over the past six months. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/initiation/25/01/43102452/roku-analyst-sees-25-upside-as-tv-ad-dollars-go-digital">Roku Analyst Sees 25% Upside As TV Ad Dollars Go Digital&nbsp;</a></li>
</ul>
Photo: Shutterstock

Biotech

Equities

Government

Markets

General

CALM

CVAC

MRNA

NVAX

Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine

Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) has outperformed the market over the past 15 years by 11.59% on an annualized basis producing an average annual return of 23.61%. Currently, Super Micro Computer has a market capitalization of $19.00 billion. 
Buying $100 In SMCI: If an investor had bought $100 of SMCI stock 15 years ago, it would be worth $2,795.00 today based on a price of $32.45 for SMCI at the time of writing.
<h3>Super Micro Computer's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737501309_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SMCI

Here's How Much $100 Invested In Super Micro Computer 15 Years Ago Would Be Worth Today

An executive order signed by President Donald Trump put an emphasis on ending electric vehicle plans put in place by former President Joe Biden and could put an end to the $7,500 tax credits that helped <a href="https://www.benzinga.com/electric-vehicles">boost the sector.</a>
What Happened: One of Trump's first tasks since becoming president <a href="https://www.benzinga.com/tech/25/01/43090016/here-are-the-evs-which-could-lose-7500-ev-tax-credit-under-trump-administration">was to sign </a>the "Unleashing American Energy" executive order.
Trump's order says he is eliminating the "electric vehicle mandate" and also terminating the Green New Deal.
While Trump may need additional approval to end the $7,500 tax credit American consumers can currently get for buying numerous electric vehicle models, including several from Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), the order pauses the disbursement of funds that were part of the Inflation Reduction Act of 2022.
The electric vehicle tax credits have helped boost sales of EVs over the past several years, including Tesla. Once a beneficiary of tax credits for his company, Tesla CEO Elon Musk has changed his tune about the credits in recent years.
Musk <a href="https://www.benzinga.com/news/24/07/39934750/trump-presidency-and-ira-cut-would-be-devastating-for-competitors-says-elon-musk-long-term-probably">said recently</a> that he was okay with the tax credits going away and has pledged his support to Trump, who he supported during the 2024 presidential election.
In a quarterly earnings call in July 2024, Musk said Trump winning the election and the end of the tax credits could be "devastating" for Tesla rivals, but would likely end up being a long-term positive for his company. &nbsp;
"Long term probably actually helps Tesla, would be my guess, yes," Musk said at the time.
With the potential of the EV tax credits going away, Tesla influencer Sawyer Merritt conducted a poll on social media platform X to see if people thought the move would help or hurt Tesla.
"Long-term is the U.S. EV credit disappearing bullish, bearish, or neutral for Tesla," Merritt asked.
Here are the poll <a href="https://x.com/SawyerMerritt/status/1881777072017649722">results</a>, based on 16,294 votes.
<ul>
<li>Bullish: 40.4%</li>
<li>Neutral: 27.5%</li>
<li>Bearish: 19.4%</li>
<li>See Results: 12.6%</li>
</ul>
The largest percentage of voters believe the EV tax credit going away would be bullish for Tesla. This is likely related to the belief that the move would be bad for most EV companies, but hurt Tesla's competitors more. Tesla has profitability per vehicle and vertical integration for manufacturing, which helps the company on costs and scale.
When asked for his opinion, Merritt said he was neutral on the potential change.
"Hard to argue that it's really bullish since Tesla is currently the largest beneficiary of the EV credit, but it disappearing I don't think will be a negative as some are suggesting. Tesla is no doubt in the strongest position to withstand the impact of it disappearing vs their legacy auto competition," Merritt said.
Read Also: <a href="https://www.benzinga.com/news/global/25/01/43088582/gary-black-questions-elon-musks-take-on-ev-credit-removal-after-tesla-sales-drop-in-europe-not-sure-how-the-math-works">Gary Black Questions Elon Musk&#8217;s Take On EV Credit Removal After Tesla Sales Drop In Europe: &#8216;Not Sure How The Math Works&#8217;</a>
Why It's Important: Musk's stance on being against tax credits that help boost the market share of electric vehicle companies could be a surprise to many given his past support for the sector.
"Since the company's inception in 2003, Tesla's mission has been to accelerate the world's transition to sustainable energy," Tesla's website <a href="https://www.tesla.com/elon-musk">reads</a>.
Musk has said in the past that the acceleration of sustainable energy is fundamental to the future of humanity, as reported by <a href="https://www.cnbc.com/2019/02/04/elon-musk-on-the-why-and-purpose-behind-tesla.html#:~:text=We%20created%20Tesla%20to%20accelerate,for%20humanity%2C%22%20Musk%20said.">CNBC</a>.
These days, Musk and Tesla are focusing heavily on autonomous vehicles which could be the next political move by the Trump administration. Trump<a href="https://www.benzinga.com/general/politics/24/10/41298125/maybe-musk-missed-the-memo-trumps-plan-to-ban-autonomous-vehicles-could-sour-friendship"> previously said he </a>would ban autonomous vehicles from American roads.
Since then, Trump may have reversed his stance and come around to help boost the future of Musk's company by pushing autonomous vehicle testing forward and making Tesla's vision a reality.
Musk has watched his wealth soar <a href="https://www.benzinga.com/news/management/24/12/42444955/elon-musk-first-person-worth-400-billion-as-tesla-stock-hits-new-all-time-highs-how-2024-election-helped-could-lead-to-future-gains">to over $400 billion</a> since Trump won the 2024 presidential election.
While the new EV tax credit rules could be bad for the electric vehicle sector over time, the current president is likely going to be good for Musk and his company. The question is what the short and long-term impacts on Tesla will be. Based on the poll, investors don't seem too concerned about the potential loss of EV tax credits.
TSLA Price Action: Tesla stock closed down 0.57% to $424.07 on Tuesday versus a 52-week trading range of $138.80 to $488.54. Tesla stock is up 103% over the last year. Tesla's drop came while many stocks were up on the first trading day after Trump's inauguration with the SPDR S&amp;P 500 ETF up 0.92% to $603.05 Tuesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/25/01/42986863/us-electric-vehicle-sales-hit-record-1-3-million-units-in-2024-despite-tesla-declines-top-10-bestsel">US Electric Vehicle Sales Hit Record 1.3 Million Units In 2024, Despite Tesla Declines: Top 10 Bestselling Models</a></li>
</ul>
Photo: Courtesy Tesla

Politics

TSLA

Trump's Plan To End $7,500 EV Tax Credits Could Be 'Devastating' For Telsa Rivals, Poll Says Could Be Bullish For Elon Musk's Company

Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) has outperformed the market over the past 20 years by 3.08% on an annualized basis producing an average annual return of 11.6%. Currently, Lockheed Martin has a market capitalization of $118.93 billion. 
Buying $100 In LMT: If an investor had bought $100 of LMT stock 20 years ago, it would be worth $897.68 today based on a price of $506.00 for LMT at the time of writing.
<h3>Lockheed Martin's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737500410_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Lockheed Martin 20 Years Ago Would Be Worth This Much Today

This is subject to the completion of the Reverse Stock Split.

GSAT

Globalstar Intends To Voluntarily Delist From NYSE American And Transfer To Nasdaq

The data will be presented in a poster session (abstract #206) at the American Society of Clinical Oncology 2025 Gastrointestinal Cancer Symposium (ASCO GI) being held January 23-25, 2025, in San Francisco.
"We are very encouraged by the initial Phase 2 proof-of-concept data for the combination of vilastobart and atezolizumab in heavily pre-treated patients with MSS colorectal cancer, including partial responses accompanied by marked decreases in tumor biomarkers and improvement in clinical symptoms," said Katarina Luptakova, M.D., chief medical officer of Xilio.

Xilio Reports Initial Data From Ongoing Phase 2 Clinical Trial Evaluating Vilastobart In Combination With Atezolizumab; 27% Preliminary Response Rate Observed In Heavily Pre-Treated Microsatellite Stable Colorectal Cancer Patients Without Liver Metastases

The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is subject to market and other conditions and the completion of the SEC's review process.

IPOs

Voyager Technologies Submits Confidential Registration Statement For Proposed IPO

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 20 years by 19.56% on an annualized basis producing an average annual return of 28.09%. Currently, Intuitive Surgical has a market capitalization of $215.49 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 20 years ago, it would be worth $13,941.23 today based on a price of $605.00 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737499516_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ISRG

Here's How Much $100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth Today

East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) has outperformed the market over the past 5 years by 3.68% on an annualized basis producing an average annual return of 16.95%. Currently, East West Bancorp has a market capitalization of $14.38 billion. 
Buying $1000 In EWBC: If an investor had bought $1000 of EWBC stock 5 years ago, it would be worth $2,106.64 today based on a price of $103.71 for EWBC at the time of writing.
<h3>East West Bancorp's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737498617_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EWBC

Here's How Much You Would Have Made Owning East West Bancorp Stock In The Last 5 Years

Contracts

GOOG

IAC Enters Further Amendment To Its Services Agreement With Google; Expiration Date Of Agreement Is Now March 31, 2026, With An Automatic Renewal For An Additional One-year Period - Filing

Roku Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) shares are trading higher in Tuesday&#8217;s after-hours session after Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) reported better-than-expected <a href="https://www.benzinga.com/25/01/43114866/netflix-q4-earnings-highlights-nfl-squid-game-power-best-subscriber-growth-in-company-history">financial results for the fourth quarter</a>.
What Happened With Netflix: Netflix reported fourth-quarter revenue of $10.25 billion, beating analysts estimates of $10.11 billion. The streaming giant reported quarterly earnings of $4.27 per share, beating analyst estimates of $4.19 per share.
Shares appear to be soaring in response to the company&#8217;s strong subscriber growth. Netflix said it added 18.91 million paid subscribers in the quarter, bringing its total subscriber count up to 301.63 million.
Netflix noted that its advertising plan continues to be quite popular, generating over 55% of sign-ups in the quarter. The company&#8217;s ads plan grew nearly 30% on a quarter-over-quarter basis.
&#8220;We're on track to reach sufficient scale for ads members in all of our ads countries in 2025. A top priority in 2025 is to improve our offering for advertisers so that we can substantially grow our advertising revenue,&#8221; the company said. 
NFLX Earnings: <a href="https://www.benzinga.com/25/01/43114866/netflix-q4-earnings-highlights-nfl-squid-game-power-best-subscriber-growth-in-company-history">Netflix Q4 Earnings: Record Subscribers, NFL, &#8216;Squid Game&#8217; Push Past &#8216;Highest Expectations&#8217;</a>
Why It Matters For ROKU: Roku is well-positioned to benefit from strong advertising trends from Netflix and other streaming companies.
Roku creates revenue opportunities with streaming companies through partnerships and advertising. The company operates an advertising distribution platform, allowing it to capitalize on the growth of streaming. Netflix was reportedly <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/06/27622300/3-reasons-why-this-analyst-thinks-a-netflix-roku-deal-may-not-materialize" target="_blank" rel="noreferrer noopener">considering a takeover of Roku</a> a couple of years ago, but a deal never materialized.
Roku is due to report its <a href="https://www.benzinga.com/calendars/earnings">fourth-quarter financial results</a> in early February, although a date has not yet been confirmed by the company. Analysts expect Roku to report a loss of 41 cents per share and revenue of $1.15 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
ROKU Price Action: <a href="http://benzinga.com/quote/roku">Roku shares</a> were up 3.71% in after-hours, trading at $82.70 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Entertainment

After-Hours Center

Movers

Media

NFLX

ROKU

Roku Stock Is Rising After-Hours Tuesday: Here's Why

As of January 17, 2025, a total of approximately 13.24 million shares remained available for repurchase under the existing repurchase authorization, resulting in an increase of 6.75 million shares of common stock available for repurchase.

Buybacks

HOMB

Home BancShares Increases Share Repurchase Program And Renew Authorization To 20M Shares

Results from Alpha-CORRECT, a study with one of the longest MRD surveillance monitoring periods to date, showed the Oncodetect test achieved 78% sensitivity at the post-surgical timepoint and 91% sensitivity during the surveillance monitoring period, with specificities of 80% and 94%, respectively.
Results from prospective molecular residual disease (MRD) study show a positive Oncodetect test result is strongly associated with recurrence in stage III colon cancer patients.
In addition to the data shared at ASCO GI, Oncodetect achieved its primary endpoint in the Beta-CORRECT study.&nbsp;
&nbsp;
&nbsp;

EXAS

Exact Sciences Says Oncodetect Test Achieved Primary Endpoint In Second Clinical Validation Study, Extending Prognostic Value Into Stages II And IV Colon Cancer And Rectal Cancer

Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) has outperformed the market over the past 15 years by 6.58% on an annualized basis producing an average annual return of 18.61%. Currently, Centene has a market capitalization of $32.14 billion. 
Buying $1000 In CNC: If an investor had bought $1000 of CNC stock 15 years ago, it would be worth $13,092.03 today based on a price of $63.66 for CNC at the time of writing.
<h3>Centene's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737497710_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today

Exact Sciences Plans To Present 11 Abstracts At ASCO GI Meeting In San Francisco

Efficacy was assessed in 10 of the 13 patients who received at least one dose of ozekibart, based on RECIST v1.1 criteria. Results demonstrated one complete response (CR), three partial responses (PR), and six cases of stable disease (SD). Durable disease control lasting ≥180 days was observed in 46.2% of patients, with a median progression-free survival (PFS) of 7.85 months.&nbsp;
Encouraged by these preliminary results, Inhibrx has initiated a new expansion cohort to validate these findings in a more uniform patient population. The cohort is expected to enroll up to 50 patients, each with two to three prior lines of systemic therapy, and data are anticipated in Q3 2025.

INBX

Inhibrx Reports Preliminary Efficacy And Safety Data From Phase 1 Trial Of Ozekibart (INBRX-109) For Treatment Of Colorectal Cancer; Initiates New Expansion Cohort To Validate Findings

ORLA

Orla Mining Says Shareholders Approved Acquisition Of Musselwhite Mine From Newmont

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning!



Moving stocks are clinical trial data, company merger plans, bankruptcy filings and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Yield10 Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/yten-stock-quote/">YTEN</a>) stock is rocketing more than 59% alongside heavy pre-market trading this morning.</li>



<li>Chenghe Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/chea-stock-quote/">CHEA</a>) shares are soaring over 37% following <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318029672&amp;type=PDF&amp;symbol=CHEA&amp;cdn=512bce218ae3f41dfa99fbb4fa603a82&amp;companyName=Chenghe+Acquisition+Co.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-02-02">shareholder approval for a merger plan</a>.</li>



<li>GRIID Infrastructure (NASDAQ:<a href="https://investorplace.com/stock-quotes/grdi-stock-quote/">GRDI</a>) stock is surging more than 34% with strong early morning trading.</li>



<li>4D Molecular Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/fdmt-stock-quote/">FDMT</a>) shares are soaring over 29% with <a href="https://www.marketwatch.com/story/4d-molecular-therapeutics-shares-rise-33-after-positive-trial-data-436613d6">positive clinical trial data</a>.</li>



<li>Tritium DCFC (NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock is gaining 28% after being the <a href="https://www.nasdaq.com/press-release/tritium-customers-win-largest-share-of-round-1-tennessee-nevi-program-2024-02-05">top-awarded fast-charger company</a> by Tennessee&rsquo;s National Electric Vehicle Infrastructure (NEVI) Formula Program.</li>



<li>Simplify Tail Risk Strategy (NYSEARCA:<a href="https://investorplace.com/stock-quotes/cya-stock-quote/">CYA</a>) shares are rising more than 17% on Monday morning.</li>



<li>Magic Empire Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/megl-stock-quote/">MEGL</a>) stock is climbing 15% as it sees heavy trading this morning.</li>



<li>BioRestorative Therapies (NASDAQ:<a href="https://investorplace.com/stock-quotes/brtx-stock-quote/">BRTX</a>) shares are jumping over 14% on Monday.</li>



<li>Alto Neuroscience (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANRO#NYSE">ANRO</a>) stock is getting a more than 14% boost following its <a href="https://www.marketwatch.com/story/alto-neuroscience-shares-soar-in-trading-debut-after-upsized-ipo-22f26d13">initial public offering</a>.</li>



<li>Catalent (NYSE:<a href="https://investorplace.com/stock-quotes/ctlt-stock-quote/">CTLT</a>) shares are up 13% after announcing a <a href="https://finance.yahoo.com/news/novo-holdings-buy-catalent-11-111946341.html">massive sale of the company</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Cano Health (NYSE:<a href="https://investorplace.com/stock-quotes/cano-stock-quote/">CANO</a>) stock is crashing more than 51% alongside <a href="https://www.nasdaq.com/press-release/cano-health-enters-restructuring-support-agreement-with-a-significant-majority-of-its">a bankruptcy filing</a>.</li>



<li>NanoString Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/nstg-stock-quote/">NSTG</a>) shares are plummeting over 49% after also <a href="https://www.nasdaq.com/press-release/nanostring-takes-steps-to-restructure-its-business-and-protect-its-mission-to-map-the">filing for bankruptcy protection</a>.</li>



<li>DMK Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmk-stock-quote/">DMK</a>) stock is diving more than 48% <a href="https://www.nasdaq.com/press-release/dmk-pharmaceuticals-commences-restructuring-proceeding-2024-02-02">following a bankruptcy filing</a>.</li>



<li>Bit Brother (NASDAQ:<a href="https://investorplace.com/stock-quotes/bets-stock-quote/">BETS</a>) shares are tumbling over 25% after getting <a href="https://www.nasdaq.com/press-release/bit-brother-limited-receives-notice-of-delisting-from-nasdaq-2024-02-02">a delisting notice</a>.</li>



<li>Jin Medical International (NASDAQ:<a href="https://investorplace.com/stock-quotes/zjyl-stock-quote/">ZJYL</a>) stock is dropping more than 18% without any clear news this morning.</li>



<li>Oragenics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ogen-stock-quote/">OGEN</a>) shares are sliding over 13% on Monday morning.</li>



<li>Rail Vision (NASDAQ:<a href="https://investorplace.com/stock-quotes/rvsn-stock-quote/">RVSN</a>) stock is decreasing more than 12% ahead of <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318029931&amp;type=PDF&amp;symbol=RVSN&amp;cdn=4bbedcb1f3a7ff960c3216adeb5f2cde&amp;companyName=Rail+Vision+Ltd.&amp;formType=6-K%2FA&amp;formDescription=%5BAmend%5D+Report+of+foreign+issuer+%5BRules+13a-16+and+15d-16%5D&amp;dateFiled=2024-02-02">an extraordinary general shareholder meeting</a>.</li>



<li>Intelligent Bio Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/inbs-stock-quote/">INBS</a>) shares are falling over 11% after <a href="https://www.globenewswire.com/news-release/2024/02/02/2822845/0/en/Intelligent-Bio-Solutions-Inc-Announces-Preliminary-Unaudited-Fiscal-Second-Quarter-and-Six-Month-Revenue-Results.html">releasing preliminary results for Q2</a>.</li>



<li>TruGolf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>) stock is retreating more than 11% following its <a href="https://investorplace.com/2024/02/why-is-trugolf-trug-stock-up-35-today/">recent public debut</a>.</li>



<li>CCSC Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cctg-stock-quote/">CCTG</a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/02/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-feb-5th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!



Moving stocks are heavy trading, earnings reports, clinical trial news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Next eGo (NASDAQ:<a href="https://investorplace.com/stock-quotes/egox-stock-quote/">EGOX</a>) stock is rocketing more than 110% alongside heavy pre-market trading this morning.</li>



<li>Intelligent Living Application (NASDAQ:<a href="https://investorplace.com/stock-quotes/ilag-stock-quote/">ILAG</a>) shares are soaring over 90% with strong early morning trading on Friday.</li>



<li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is surging more than 75% with increased trading activity this morning.</li>



<li>Top Financial (NASDAQ:<a href="https://investorplace.com/stock-quotes/top-stock-quote/">TOP</a>) shares are gaining over 75% as it also experiences heavy trading on Friday.</li>



<li>Sunworks (NASDAQ:<a href="https://investorplace.com/stock-quotes/sunw-stock-quote/">SUNW</a>) stock is rising more than 38% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318035511&amp;type=PDF&amp;symbol=SUNW&amp;cdn=adc51c5aed5c71e14427762a8cf482ab&amp;companyName=Sunworks+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-02-06">despite a recent bankruptcy filing</a>.</li>



<li>Cheche (NASDAQ:<a href="https://investorplace.com/stock-quotes/ccg-stock-quote/">CCG</a>) shares are increasing over 30% without any clear news today.</li>



<li>Cloudflare (NYSE:<a href="https://investorplace.com/stock-quotes/net-stock-quote/">NET</a>) stock is climbing more than 27% <a href="https://www.cnbc.com/2024/02/08/cloudflare-net-q4-earnings-report-2023.html">alongside an earnings beat</a>.</li>



<li>Magic Empire Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/megl-stock-quote/">MEGL</a>) shares are jumping over 26% alongside strong early morning trading on Friday.</li>



<li>Central Garden &amp; Pet (NASDAQ:<a href="https://investorplace.com/stock-quotes/centa-stock-quote/">CENTA</a>) stock is getting a 25% boost <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318045374&amp;type=PDF&amp;symbol=CENT&amp;cdn=10c65ab88aa3d8ef8e519b4adb7f0d23&amp;companyName=Central+Garden+%26+Pet+Company&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-02-08">on insider buying</a>.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) shares are up more than 18% with strong trading this morning.</li>
</ol><h2>10 Top Losers</h2><ol></ol><ol><li>Synlogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/sybx-stock-quote/">SYBX</a>) stock is plummeting 58% after <a href="https://finance.yahoo.com/news/synlogic-announces-decision-discontinue-synpheny-211500711.html">discontinuing a clinical trial</a>.</li>



<li>BioXcel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/btai-stock-quote/">BTAI</a>) shares are diving over 40% after <a href="https://www.globenewswire.com/news-release/2024/02/08/2826423/0/en/BioXcel-Therapeutics-Announces-Proposed-Public-Offering.html">announcing a proposed public offering</a>.</li>



<li>Children&rsquo;s Place (NASDAQ:<a href="https://investorplace.com/stock-quotes/plce-stock-quote/">PLCE</a>) stock is tumbling more than 31% after releasing <a href="https://www.nasdaq.com/press-release/the-childrens-place-announces-preliminary-unaudited-results-for-the-fourth-quarter-0">preliminary earnings results</a>.</li>



<li>Renalytix (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnlx-stock-quote/">RNLX</a>) shares are taking a close to 27% beating as it comes off a rally yesterday.</li>



<li>Syra Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/syra-stock-quote/">SYRA</a>) stock is dropping over 25% following a <a href="https://investorplace.com/2024/02/why-is-syra-health-syra-stock-up-285-today/">massive rally on Thursday</a>.</li>



<li>MicroCloud Hologram (NASDAQ:<a href="https://investorplace.com/stock-quotes/holo-stock-quote/">HOLO</a>) shares are retreating more than 25% after <a href="https://investorplace.com/2024/02/microcloud-hologram-holo-stock-pops-another-10-in-speculative-rally/">rallying the last two days</a>.</li>



<li>Hitek Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/hkit-stock-quote/">HKIT</a>) stock is sliding over 22% after a <a href="https://investorplace.com/2024/02/why-is-hitek-global-hkit-stock-up-518-today/">massive jump in price yesterday</a>.</li>



<li>Emcore (NASDAQ:<a href="https://investorplace.com/stock-quotes/emkr-stock-quote/">EMKR</a>) shares are falling more than 20% with its <a href="https://qz.com/emcore-fiscal-q1-earnings-snapshot-1851240456">latest earnings release</a>.</li>



<li>CCSC Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cctg-stock-quote/">CCTG</a>) stock is slipping over 18% <a href="https://investorplace.com/2024/02/why-is-ccsc-technology-cctg-stock-up-107-today/">after a Thursday rally</a>.</li>



<li>MoneyHero (NASDAQ:<a href="https://investorplace.com/stock-quotes/mny-stock-quote/">MNY</a>) stock closes out our pre-market stock movers down more than 18% <a href="https://finance.yahoo.com/news/moneyhero-group-announces-resignation-chief-213000993.html">as its Chief Financial Officer resigns</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/02/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-feb-9th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Magic Empire Global gets non-compliance notice from Nasdaq

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Shares of MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock are surging higher by over 650% after the company announced that it would establish a micro-consciousness quantum research center in collaboration with WiMi (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>), its <a href="http://ir.microalgor.com/Upload/2024-04-12/6618a007c924d.pdf">parent company</a>. The research center will combine several disciplines, including physics, polymer chemistry and philosophy, in order to advance the study of consciousness.



&ldquo;The micro-consciousness quantum research center builds a bridge between basic science and applied technology, closely connecting the theoretical research of basic science and the practice of applied technology,&rdquo; said MicroAlgo.



The center&rsquo;s research will focus on four aspects: the Quantum computing and consciousness model, brain-computer interface technology, big data artificial intelligence (AI) and quantum consciousness and quantum-driven generative consciousness.



MicroAlgo and WiMi&rsquo;s research center will also collaborate with Chinese universities and research institutions on shared research, laboratory building and training.



MicroAlgo did not provide any further details, such as the costs to build such a center and any potential revenue impact. As a result, the move in MLGO is highly unusual and likely to reverse, echoing previous unusual moves in Chinese companies like AMTD Digital (NYSE:<a href="https://investorplace.com/stock-quotes/hkd-stock-quote/">HKD</a>) and Magic Empire Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/megl-stock-quote/">MEGL</a>). It&rsquo;s also worth noting that MLGO&rsquo;s float of <a href="https://finance.yahoo.com/quote/MLGO/key-statistics/">1.87 million shares</a> is extremely small, making the stock susceptible to sudden, volatile movements.



MicroAlgo&rsquo;s <a href="http://www.microalgor.com/">website</a> is also bare-bones and does not provide much information about the company.



<h2>5 Investors Betting Big on MLGO Stock in Q1</h2>



Tracking <a href="https://whalewisdom.com/stock/vena">institutional ownership</a> is important, as these large investors provide liquidity and support for stocks. However, MicroAlgo&rsquo;s institutional ownership is almost nonexistent, likely due to its status as a penny stock, falling sales and a lack of profitability.



As of the first quarter, only four 13F filers disclosed a stake in MLGO stock, a decline of nine filers compared to the prior quarter. These filers own a total of 10,862 shares, down by 77.52% from 48,313 shares during Q4. In addition, zero hedge funds reported a stake in the company.



The message from the Q1 13F data is quite clear: no one really cares or knows about MicroAlgo. With that in mind, let&rsquo;s take a look at its top shareholders as of Q1:



<ol><li>WiMi: 3.69 million shares. WiMi Q1 13D filing showed that it added 800,000 shares.</li>



<li>Chairman Jie Zhao: 1.85 million shares, accurate as of Dec. 31. These shares are owned by WiMi, while Zhao owns 100% of its Class A ordinary shares.</li>



<li>UBS Group (NYSE:<a href="https://investorplace.com/stock-quotes/ubs-stock-quote/">UBS</a>): 9,444 shares. UBS added 9,298 shares during Q1.</li>



<li>Tower Research Capital: 967 shares. Tower Research added 821 shares during Q1.</li>



<li>Morgan Stanley (NYSE:<a href="https://investorplace.com/stock-quotes/ms-stock-quote/">MS</a>): 450 shares. Morgan Stanley sold 204 shares during Q1.</li>
</ol>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;Penny Stocks &mdash; <a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>&nbsp;



On the date of publication, Eddie Pan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.&nbsp;
<div>Eddie Pan specializes in institutional investments and insider activity. He writes for InvestorPlace&rsquo;s Today&rsquo;s Market team, which centers on the latest news involving popular stocks.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/5-investors-betting-on-microalgo-mlgo-stock-in-q1/">5 Investors Betting on MicroAlgo (MLGO) Stock in Q1</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

5 Investors Betting on MicroAlgo (MLGO) Stock in Q1

Magic Empire Global Ltd. (MEGL) has released an update. Magic Empire Global Limited has received an additional 180 days from Nasdaq to meet the min...

Magic Empire Global Granted Nasdaq Compliance Extension

Magic Empire Global Ltd. (MEGL) has released an update. Magic Empire Global Ltd. reported a significant 26.9% increase in revenue for the first hal...

Magic Empire Global Ltd. Sees Revenue Surge Amid Rising Costs

Magic Empire Global Limited reports 1H results

Magic Empire Global Ltd. (MEGL) has released an update. Magic Empire Global Ltd. has scheduled its annual shareholder meeting for November 29, 2024...

Magic Empire Global Ltd. Announces Key Shareholder Meeting

Magic Empire Global Ltd. (MEGL) has released an update. Magic Empire Global Ltd. successfully held its 2024 annual general meeting where key resolu...

Magic Empire Global Ltd. Restructures Share Classes and Leadership

ANRO

BETS

BRTX

BTAI

CANO

CCTG

CENTA

CHEA

CTLT

DCFC

EGOX

EMKR

FDMT

GRDI

HKIT

HOLO

ILAG

INBS

MEGL

MLGO

NSTG

OGEN

PLCE

RNLX

RVSN

SLNA

SUNW

SYBX

SYRA

TCBP

TRUG

WIMI

YTEN

ZJYL

Press Releases

Magic Empire Global Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Magic Empire Global Limited Announces Receipt of Nasdaq Notification of additional 180 calendar day period to regain compliance of minimum bid price requirement

Magic Empire Global Limited Announces First Half 2024 Unaudited Financial Results

AMTD IDEA Group American Depositary Shares, each representing six (6) Class A Ordinary Shares

AMTD IDEA

AtlasClear Holdings

Dominari Holdings

Garden Stage

Lion Group Holding Ltd. - American Depositary Share

Lion Group Holding

MDB Capital Holdings, LLC - Class A common

MDB Capital Holdings

Magic Empire Glb

mF International Limited - Class A Ordinary Shares

mF International

Marex Group

Oppenheimer Holdings, Inc. Class A Common Stock (DE)

Oppenheimer Hldgs

Perella Weinberg Partners - Class A Common Stock

Perella Weinberg

B. Riley Financial

Siebert Finl

Solowin Holdings - Class A Ordinary Share

Solowin Holdings

UP Fintech Holding Limited - American Depositary Shares representing fifteen Class A Ordinary Shares

UP Fintech Holding

TOP Financial Group Limited - Class A Ordinary Shares

TOP Finl Gr

Virtu Financial, Inc. - Class A Common Stock

Virtu Finl

Top KingWin Ltd - Class A Ordinary Shares

Comments

Magic Empire Glb

Vendite allo scoperto

Magic Empire Glb (NASDAQ:MEGL) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO